EP1073902A2 - Particule de la taille du nanometre comportant une monocouche reactive adsorbee, et son procede d'obtention - Google Patents
Particule de la taille du nanometre comportant une monocouche reactive adsorbee, et son procede d'obtentionInfo
- Publication number
- EP1073902A2 EP1073902A2 EP99953384A EP99953384A EP1073902A2 EP 1073902 A2 EP1073902 A2 EP 1073902A2 EP 99953384 A EP99953384 A EP 99953384A EP 99953384 A EP99953384 A EP 99953384A EP 1073902 A2 EP1073902 A2 EP 1073902A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- group
- monolayer
- mixtures
- core
- particle according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002245 particle Substances 0.000 title claims abstract description 73
- 239000002356 single layer Substances 0.000 title claims abstract description 62
- 239000000463 material Substances 0.000 claims abstract description 58
- 229910052751 metal Inorganic materials 0.000 claims abstract description 24
- 239000002184 metal Substances 0.000 claims abstract description 24
- 238000005859 coupling reaction Methods 0.000 claims abstract description 16
- 230000008878 coupling Effects 0.000 claims abstract description 14
- 238000010168 coupling process Methods 0.000 claims abstract description 14
- 229910001092 metal group alloy Inorganic materials 0.000 claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 49
- 239000000203 mixture Substances 0.000 claims description 42
- 238000006243 chemical reaction Methods 0.000 claims description 29
- 125000001424 substituent group Chemical group 0.000 claims description 25
- 238000005481 NMR spectroscopy Methods 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 20
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 18
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 12
- 230000015572 biosynthetic process Effects 0.000 claims description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 229910052717 sulfur Inorganic materials 0.000 claims description 8
- 229910045601 alloy Inorganic materials 0.000 claims description 7
- 239000000956 alloy Substances 0.000 claims description 7
- 150000002484 inorganic compounds Chemical class 0.000 claims description 7
- 229910010272 inorganic material Inorganic materials 0.000 claims description 7
- 150000002894 organic compounds Chemical class 0.000 claims description 7
- 150000002902 organometallic compounds Chemical class 0.000 claims description 7
- 239000008204 material by function Substances 0.000 claims description 6
- 238000004458 analytical method Methods 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- 125000000524 functional group Chemical group 0.000 claims description 4
- 239000004065 semiconductor Substances 0.000 claims description 4
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- RROBIDXNTUAHFW-UHFFFAOYSA-N benzotriazol-1-yloxy-tris(dimethylamino)phosphanium Chemical compound C1=CC=C2N(O[P+](N(C)C)(N(C)C)N(C)C)N=NC2=C1 RROBIDXNTUAHFW-UHFFFAOYSA-N 0.000 claims description 3
- 239000012620 biological material Substances 0.000 claims description 3
- 239000002555 ionophore Substances 0.000 claims description 3
- 230000000236 ionophoric effect Effects 0.000 claims description 3
- 239000003446 ligand Substances 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 235000000346 sugar Nutrition 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- 238000004566 IR spectroscopy Methods 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 229910052796 boron Inorganic materials 0.000 claims description 2
- 230000005281 excited state Effects 0.000 claims description 2
- 229910044991 metal oxide Inorganic materials 0.000 claims description 2
- 150000004706 metal oxides Chemical class 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 230000027756 respiratory electron transport chain Effects 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims description 2
- 229910003204 NH2 Inorganic materials 0.000 claims 3
- 150000002148 esters Chemical class 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 claims 1
- 150000003222 pyridines Chemical class 0.000 claims 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 33
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 26
- UHOVQNZJYSORNB-MZWXYZOWSA-N benzene-d6 Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-MZWXYZOWSA-N 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- -1 antibodies Substances 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
- 229910052737 gold Inorganic materials 0.000 description 7
- 239000010931 gold Substances 0.000 description 7
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 7
- YZVWKHVRBDQPMQ-UHFFFAOYSA-N 1-aminopyrene Chemical compound C1=C2C(N)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 YZVWKHVRBDQPMQ-UHFFFAOYSA-N 0.000 description 6
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 6
- ASDLSKCKYGVMAI-UHFFFAOYSA-N 9,10-dioxoanthracene-2-carboxylic acid Chemical compound C1=CC=C2C(=O)C3=CC(C(=O)O)=CC=C3C(=O)C2=C1 ASDLSKCKYGVMAI-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 6
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 5
- 235000019260 propionic acid Nutrition 0.000 description 5
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- XUXUHDYTLNCYQQ-UHFFFAOYSA-N 4-amino-TEMPO Chemical compound CC1(C)CC(N)CC(C)(C)N1[O] XUXUHDYTLNCYQQ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 4
- 238000000527 sonication Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 4
- 229940045145 uridine Drugs 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 3
- QVHJQCGUWFKTSE-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound OC(=O)C(C)NC(=O)OC(C)(C)C QVHJQCGUWFKTSE-UHFFFAOYSA-N 0.000 description 3
- VCZANYLMPFRUHG-UHFFFAOYSA-N 2-naphthalen-2-ylethanol Chemical compound C1=CC=CC2=CC(CCO)=CC=C21 VCZANYLMPFRUHG-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 3
- 238000003869 coulometry Methods 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 3
- 238000002848 electrochemical method Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 description 3
- 229950000688 phenothiazine Drugs 0.000 description 3
- MFUFBSLEAGDECJ-UHFFFAOYSA-N pyren-2-ylamine Natural products C1=CC=C2C=CC3=CC(N)=CC4=CC=C1C2=C43 MFUFBSLEAGDECJ-UHFFFAOYSA-N 0.000 description 3
- TXQWFIVRZNOPCK-UHFFFAOYSA-N pyridin-4-ylmethanamine Chemical compound NCC1=CC=NC=C1 TXQWFIVRZNOPCK-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ZYJPUMXJBDHSIF-NSHDSACASA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZYJPUMXJBDHSIF-NSHDSACASA-N 0.000 description 2
- 238000004435 EPR spectroscopy Methods 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000002484 cyclic voltammetry Methods 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- PGSQAWGYMLHMKN-PSFXMQAVSA-N (2s,3s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)OC(C)(C)C.CC[C@H](C)[C@@H](C(O)=O)NC(=O)OC(C)(C)C PGSQAWGYMLHMKN-PSFXMQAVSA-N 0.000 description 1
- QJCNLJWUIOIMMF-YUMQZZPRSA-N (2s,3s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)OC(C)(C)C QJCNLJWUIOIMMF-YUMQZZPRSA-N 0.000 description 1
- GWOLZNVIRIHJHB-UHFFFAOYSA-N 11-mercaptoundecanoic acid Chemical compound OC(=O)CCCCCCCCCCS GWOLZNVIRIHJHB-UHFFFAOYSA-N 0.000 description 1
- ULGGZAVAARQJCS-UHFFFAOYSA-N 11-sulfanylundecan-1-ol Chemical compound OCCCCCCCCCCCS ULGGZAVAARQJCS-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- WUPHOULIZUERAE-UHFFFAOYSA-N 3-(oxolan-2-yl)propanoic acid Chemical compound OC(=O)CCC1CCCO1 WUPHOULIZUERAE-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- GPXJNWSHGFTCBW-UHFFFAOYSA-N Indium phosphide Chemical compound [In]#P GPXJNWSHGFTCBW-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005600 alkyl phosphonate group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000001504 aryl thiols Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910052980 cadmium sulfide Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZHYHKXNRKQTQFP-UHFFFAOYSA-N cyclopenta-1,3-diene cyclopenta-1,3-diene-1-thiol iron(2+) Chemical compound [Fe++].c1cc[cH-]c1.Sc1ccc[cH-]1 ZHYHKXNRKQTQFP-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical class Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 238000001362 electron spin resonance spectrum Methods 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000004993 emission spectroscopy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002343 gold Chemical class 0.000 description 1
- ORTRWBYBJVGVQC-UHFFFAOYSA-N hexadecane-1-thiol Chemical compound CCCCCCCCCCCCCCCCS ORTRWBYBJVGVQC-UHFFFAOYSA-N 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 238000005442 molecular electronic Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000007040 multi-step synthesis reaction Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 150000002990 phenothiazines Chemical class 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000004832 voltammetry Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0004—Preparation of sols
- B01J13/0043—Preparation of sols containing elemental metal
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
Definitions
- the invention generally relates to nanometer-sized particles which have been chemically modified and methods of making the same.
- nanotechnology relates to the art and science of building molecular materials so that they are capable of functioning as macro-scale structures and/or exhibiting physical and chemical properties which are intermediate between molecular and bulk materials. Applications involving nanotechnology are potentially far reaching. Areas of possible interest relate to, for example, catalysis, molecular electronics, biotechnology, composite materials, solar energy conversion, and the like. Investigative efforts regarding nanotechnology have focused largely on understanding the physical behavior and structure of nanometer-sized materials. Reiss, H., Proceedings of the Welch Foundation 39 th Conference on Chemical Research: Nanophase Chemistry (1995) 49-66 discusses thermodynamic behavior associated with nanophase technology.
- Nanometer-sized gold particles can be chemically attached to metal surfaces, such as electrodes.
- the purpose of such experiments is to allow the researcher to add functionality onto the immobilized particles in order to add value to the metal surface.
- Metal sols are small particles which are insoluble, and thus suspended, in the liquid in which they are dispersed. Numerous recent studies have investigated methods for adding to the complexity of metal sols. For example, Mirkin, C.A., et al., Nature 382 (1996) 607-609, proposes attaching oligonucleotides to gold sols in order to promote aggregation of said sols upon addition of an appropriate complementary oligonucleotide to the sol solution.
- U.S. Patent No. 4,859,612 to Cole et al. proposes that antibody coated metal sols can interact with an appropriately coated solid phase particle as a means for an immunoassay procedure.
- Soc, 117:50 (1995) 12537-12548 proposes nanometer- sized gold cores which are stabilized by chemisorbed layers of octane- or hexadecanethiolate. These monolayer-protected gold clusters were found to be highly stable as determined by differential scanning calorimetry techniques.
- Hostetler, M.J., et al., Langmuir, 12 (1996) 3604-3612 relates to the evaluation of the physical structure of alkanethiolates of various chain lengths adsorbed onto nanometer-sized gold cores. Alkanethiolates with shorter chain lengths were determined to be relatively disordered while materials with longer chain lengths were found to be in the trans zig-zag conformation.
- the previous three descriptions of the art represent nanometer-sized gold cores covered with simple, non-derivatized alkanethiols, a circumstance that severely limits their applicability.
- nanometer-sized materials which exhibit specific chemical and physical properties. More particularly, there is a need for such materials which can be tailored for utilization in a number of defined end use applications. It would be particularly desirable if the nanometer-sized particles exhibited flexible chemical behavior as well as
- the invention relates to a functionalized nanometer- sized particle comprising a core which comprises at least one metal or metal 120 alloy; and a monolayer chemically bonded to the core.
- the monolayer is formed during the formation of the core and can be modified at any time following formation of the core.
- the monolayer contains at least one reactive substituent thereon which is coupled to a functional material such that the monolayer becomes chemically modified.
- the reactive substituent may be 125 selected from a number of groups such as, for example, SH, OH, NH 2 , NH, C0 2 H, SO 3 OH, P0 2 (OH) 2 , BO(OH) 2 , or mixtures thereof.
- a number of functional materials may be employed such as catalysts, biomaterials, and materials which are chemically, electrochemically, or photochemically active.
- the particles may be readily
- the invention in another aspect, relates to a method of making a functionalized nanometer-sized particle.
- the method comprises providing a nanometer-sized particle comprising: (1) a core which comprises at least one metal or metal alloy and (2) a monolayer chemically bonded to the core, the
- the nanometer-sized particle is then coupled with a functional material such that the monolayer becomes chemically modified.
- this method allows for the particle to be modified based on a small subset of reactive substituents, all of which can be readily synthesized or purchased commercially. Adding greater value to said
- nanometer-sized particle can then be accomplished using a variety of functional materials.
- FIG. 1 is a representation of a multi-step synthesis of a tripeptide- functionalized monolayer-protected nanometer-sized gold core.
- FIG. 2a is a graph illustrating the electrochemical characterization of a 10H-(phenothiazine-10)propionic acid-functionalized monolayer-protected nanometer-sized gold core. Specifically, the figure illustrates the cyclic 150 voltammetry of 0.8 mM 70H-(phenothiazine-10)propionic acid (-) in 2:1 toluene/acetonitrile (v/v) at 10OmV/s; and
- the invention relates to a functionalized nanometer-sized particle.
- the functionalized nanometer-sized particle comprises a core
- the core preferably has a diameter ranging from about 1 nm to about 999 nm, more preferably from about 1 nm to about 100 nm; even more preferably from about 1 nm to about 20 nm; and most preferably from about 1 nm to about 7 nm.
- a monolayer is chemisorbed or chemically bonded to the core. The monolayer
- 170 contains at least one reactive substituent as described further herein.
- the reactive substituent(s) on the monolayer is/are coupled to a functional material so as to chemically modify the monolayer.
- metals and metal alloys may be used in the core.
- the metal or metal alloy is selected from the group consisting of
- a semiconducting material a metal oxide material, a Group VIIIA element, a
- the metal or metal alloy is selected from the group consisting of a Group VIIIA element, a Group IB element, alloys thereof, and mixtures thereof. Examples of elements which may be used include, but are not limited to, gold,
- Examples of semiconducting materials include, but are not limited to, cadmium sulfide, indium phosphide, and other Group lll-V materials.
- Example of oxide materials include, but are not limited to, titanium oxide (titania), aluminum oxide (alumina), tin oxide, and iron oxide.
- the shape of the core is not restricted to any particular 185 geometry, thus, for example, rods, spheres, cuboctahedra, and truncated octahedra, will all satisfy the conditions stated herein.
- the term "monolayer” may be defined as a layer preferably having a thickness ranging from about 0.4 nm to about 100 nm, and more preferably 1.0 to 20 nm.
- the monolayer is typically formed during the formation of the core, and the monolayer can be modified at any point following formation of the core.
- the monolayer which is adsorbed or chemically bonded to the core may comprise a number of materials. Examples of these materials include, but are not limited to, organic compounds (e.g., alkanethiols, arylthiols, vinylthiols,
- inorganic compounds e.g., alkyl borates, alkyl phosphonates, alkyl silicates), organometallic compounds (e.g., ferrocenethiol); biochemical compounds (e.g., cysteine, albumin, coenzyme A), and mixtures thereof.
- the monolayer include, for example, branched molecules
- the monolayer may comprise an alkanethiol or an alkanethiol derivative.
- Exemplary alkanethiols include those having between 2 and 23 carbon atoms.
- the monolayer contains at least one reactive substituent.
- reactive substituent refers to those substituents which are chemically active so that, upon reaction with a functional material, part of the reactive substituent remains with the
- reactive substituents include, but are not limited to, SH, OH, NH 2 , NH, C0 2 H, S0 3 OH, P0 2 (OH) 2 , BO(OH) 2 , and mixtures thereof. More preferably, OH, NH, C0 2 H, NH 2 , and mixtures thereof are employed. Examples of compounds which may be present
- R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof;
- E is selected from the group consisting of S, O, NH, COO,
- n is an integer ranging from 1 to 5 (more preferably from 1 to 2); and x is an integer ranging from 1 to 10 (more preferably from 1 to 3). More preferably, E is selected from O, NH, C0 2 , NH 2 , and mixtures thereof.
- the chemically modified monolayer may also include partially reactive and nonreactive compounds or materials.
- nonreactive compounds or materials may be used in any ratio so long as at least one reactive compound or material is present on the monolayer.
- the monolayer is preferably chemically bonded to the core by various types of bonds.
- bonds include, but are not limited to, core- element-sulfur bonds, core-element-oxygen-bonds, core-element-boron, core-
- the monolayer is chemically bonded to the core by various core-element-sulfur bonds.
- core-element refers to any element of which the core is composed.
- the monolayer is coupled to a functional material such that the monolayer is chemically modified.
- the term "coupled” may be interpreted to mean that the monolayer and the functional material are linked via formation of a new chemical bond. Examples, include, but are not limited to amide, thioester, and ester-forming reactions known in the art.
- Examples of functionalities which may be present on the functional materials include, but are not limited to, SH, OH, NH 2 , NH, C0 2 H, S0 3 OH, P0 2 (OH) 2 , BO(OH) 2 , and mixtures thereof.
- Examples of reactive substituents include, but are not limited to, SH, OH, NH 2 , NH, C0 2 H, S0 3 OH, P0 2 (OH) 2 , BO(OH) 2 , and mixtures thereof. More preferably, OH, NH, C0 2 H, NH 2 , and mixtures thereof
- the functional material may also comprise at least one compound having the general formula:
- R n (EH) x wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound,
- E is selected from the group consisting of S, O, NH, COO,
- n is an integer ranging from 1 to 5 (more preferably from 1 to 2); and x is an integer ranging from 1 to 10 (more preferably from 1 to 3). More preferably, E is selected from O, NH, C0 2 , NH 2 , and mixtures thereof. It should be emphasized that the
- the functional material may be present in the form of a number of structures which possesses functionality in the manner described herein.
- the functional material may be a catalyst, a biomaterial, a material which is electrochemically active, or combinations thereof.
- the functional material may also be one which has a low-lying excited state which is capable of undergoing
- the functional material may also be selected such that the nanometer-sized particle is soluble in a solvent.
- soluble may be defined to mean the particles being dispersed or dissolved in the solvent.
- suitable solvents include aqueous or organic solvents.
- the invention relates to a method of making a functionalized nanometer-sized particle.
- the method comprises providing a nanometer-sized particle comprising a core which comprises at least one metal or metal alloy, and a monolayer adsorbed onto the core.
- the monolayer includes at least one reactive substituent.
- the nanometer-sized particle is then
- a number of functional materials may be used in the above method. Examples of these materials include, but are not limited to, spin labels (e.g., 4- amino-TEMPO), metal ligands (e.g., 4-(aminomethyl)-pyridine), amino acids
- chromophores and fluorophores e.g., 1- aminopyrene and 2-naphthaleneethanol
- ionophores e.g., 2-(aminomethyl)-15- crown-5
- molecules susceptible to functional group conversion e.g., benzyl amine
- electroactive molecules e.g., ferrocene methanol, " OH-(phenothiazine- 10) propionic acid, anthraquinone-2-carboxylic acid
- sugars e.g., ⁇ -D-glucose
- nucleotides e.g., uridine
- the coupling step is preferably carried out in the presence of a reagent which may be, for example, a phophonium reagent, a facilitating reagent, as well as mixtures thereof.
- a reagent which may be, for example, a phophonium reagent, a facilitating reagent, as well as mixtures thereof.
- the facilitating reagent may be selected from a base, a catalyst, and mixtures thereof.
- Preferred bases include various pyridine
- components which may be employed during the coupling step include, but are not limited to, BOP (benzotriazol-1- yloxytris(dimethylamino)phosphonium hexafluorophosphate); HOBt (1- hydroxybenzotriazole); NMM (4-methylmorpholine); DMAP (4- dimethylaminopyridine); and mixtures thereof
- the invention in another aspect, relates to a method of analyzing a nanometer-sized particle.
- the method comprises subjecting a nanometer-sized particle as defined herein to an analytical technique such that the composition of the functional materials of the monolayer on the particle are determined.
- an analytical technique such that the composition of the functional materials of the monolayer on the particle are determined.
- a number of analytical techniques may be employed in this method. Examples of
- such techniques include, but are not limited to, NMR spectroscopy, electrochemical techniques, fluorescent emission spectroscopies, and infrared spectroscopies. Examples
- 345 are those that are unique to each functionalized monolayer-protected nanometer-sized gold core (an infrared spectra of a nanometer-sized gold core which is stabilized by chemisorbed layers of dodecanethiolate was used for background subtraction).
- BOP benzotriazol-1- yloxytris(dimethylamino)phosphonium hexafluorophosphate
- HOBt 1- hydroxybenzotriazole
- NMM 4-methylmorpholine
- DMAP dimethylaminopyridine
- 4-amino-TEMPO 4-amino-2, 2,6,6-
- CD 2 CI 2 ⁇ (ppm) - 0.9 (br, 17 H), 1.3 (br, 150 H), 2.75 (br, 0.2 H), 4.0 (br, 2 H), 4.1 (br, 2 H), 6.8 (br, 5.9 H), 7.1 (br, 5.9 H)
- IR 2851 (d + ), 2921 (d ), 1817, 1733, 1700, 1633, 1616, 1491 , 1411 , 843, 782, 764, 742 cm "1 .
- the electrochemistry of this MPC derivative is shown in Figure 3a. The percent conversion to number 495 coupled ratio was determined to be 65/7.4.
- Cyclic voltammetry (seen in Figure 2) was performed with a BAS 100B electrochemical analyzer sold by Bioanalytical Systems, Inc., located in West Lafayette, Indiana. A platinum 3 mm diameter working electrode was polished with 0.5 ⁇ m diamond (Buehler) paste followed by rinsing with water, ethanol, and
- Thin-layer coulometry (as seen in Figure 2b) was performed using a BAS 590 100B electrochemical analyzer.
- a 4.3 mm diameter Pt working electrode was polished with 0.5 ⁇ m of diamond (Buehler) paste followed by rinsing with water, ethanol, and acetone and toluene prior to each experiment.
- a Pt wire counter electrode and Ag wire quasi-reference electrode (AgQRE) resided in a locally designed thin-layer cell as defined in Reilley, C.N., Pure Appl. Chem. 18 (1968) 595 137.
- a Mitutoyo digital micrometer (1-2", 0.00005" resolution) sold by Mitutoyo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Nanotechnology (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Powder Metallurgy (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Abstract
L'invention porte sur une particule de la taille du nanomètre comportant un noyau fait d'au moins un métal et un alliage et une monocouche liée chimiquement au noyau. La monocouche comprend au moins un substituant réactif couplé à un matériau fonctionnel la modifiant chimiquement. L'invention porte également sur un procédé d'obtention d'une particule fonctionnalisée de la taille du nanomètre consistant à prendre une particule de la taille du nanomètre comportant un noyau fait d'au moins un métal et un alliage, et une monocouche adsorbée sur le noyau et comprenant au moins un substituant réactif, et à coupler ladite particule à un matériau fonctionnel modifiant chimiquement la monocouche.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62863 | 1987-06-16 | ||
| US6286398A | 1998-04-20 | 1998-04-20 | |
| PCT/US1999/007823 WO1999061911A2 (fr) | 1998-04-20 | 1999-04-09 | Particule de la taille du nanometre comportant une monocouche reactive adsorbee, et son procede d'obtention |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1073902A2 true EP1073902A2 (fr) | 2001-02-07 |
Family
ID=22045338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP99953384A Withdrawn EP1073902A2 (fr) | 1998-04-20 | 1999-04-09 | Particule de la taille du nanometre comportant une monocouche reactive adsorbee, et son procede d'obtention |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1073902A2 (fr) |
| AU (1) | AU6016999A (fr) |
| CA (1) | CA2329859A1 (fr) |
| WO (1) | WO1999061911A2 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6316100B1 (en) | 1997-02-24 | 2001-11-13 | Superior Micropowders Llc | Nickel powders, methods for producing powders and devices fabricated from same |
| GB0025414D0 (en) | 2000-10-16 | 2000-11-29 | Consejo Superior Investigacion | Nanoparticles |
| US6653653B2 (en) | 2001-07-13 | 2003-11-25 | Quantum Logic Devices, Inc. | Single-electron transistors and fabrication methods in which a projecting feature defines spacing between electrodes |
| US6483125B1 (en) | 2001-07-13 | 2002-11-19 | North Carolina State University | Single electron transistors in which the thickness of an insulating layer defines spacing between electrodes |
| GB0126236D0 (en) | 2001-11-01 | 2002-01-02 | Univ East Anglia | Photosensitiser functionalised nanoparticles |
| US6673717B1 (en) | 2002-06-26 | 2004-01-06 | Quantum Logic Devices, Inc. | Methods for fabricating nanopores for single-electron devices |
| GB0313259D0 (en) * | 2003-06-09 | 2003-07-16 | Consejo Superior Investigacion | Magnetic nanoparticles |
| FR2859117B1 (fr) * | 2003-08-27 | 2006-02-03 | Commissariat Energie Atomique | Utilisation de nanoparticules a coeur metallique et double enrobage organique en tant que catalyseurs et nanoparticules utiles comme catalyseurs |
| JP5117191B2 (ja) * | 2004-10-01 | 2013-01-09 | ミダテック リミテッド | 抗原及びアジュバントを含むナノ粒子、並びに免疫原性構造 |
| TW200640596A (en) | 2005-01-14 | 2006-12-01 | Cabot Corp | Production of metal nanoparticles |
| US7824466B2 (en) | 2005-01-14 | 2010-11-02 | Cabot Corporation | Production of metal nanoparticles |
| WO2006076608A2 (fr) | 2005-01-14 | 2006-07-20 | Cabot Corporation | Systeme et procede de fabrication de composants electroniques sur mesure par combinaison d'electronique traditionnelle et d'electronique imprimable |
| CN1305977C (zh) * | 2005-03-04 | 2007-03-21 | 北京化工大学 | 用转移法对纳米级无机颗粒表面改性的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2026409C (fr) * | 1989-09-29 | 2004-11-09 | Ernest G. Schutt | Methode de production d'un reactif contenant une distribution etroite de particules colloidales d'une grosseur choisie et son utilisation |
| GR1000686B (el) * | 1989-11-16 | 1992-10-08 | Ortho Diagnostic Systems Inc | Μεθοδος παραγωγης ενος αντιδραστηριου κολλοειδους μεταλλου που περιεχει κολλοειδη τεμαχιδια μεταλλου με προκαθορισμενο μεγεθος. εθος. |
-
1999
- 1999-04-09 EP EP99953384A patent/EP1073902A2/fr not_active Withdrawn
- 1999-04-09 AU AU60169/99A patent/AU6016999A/en not_active Abandoned
- 1999-04-09 WO PCT/US1999/007823 patent/WO1999061911A2/fr not_active Ceased
- 1999-04-09 CA CA002329859A patent/CA2329859A1/fr not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9961911A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU6016999A (en) | 1999-12-13 |
| CA2329859A1 (fr) | 1999-12-02 |
| WO1999061911A3 (fr) | 2000-03-09 |
| WO1999061911A2 (fr) | 1999-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Templeton et al. | Gateway reactions to diverse, polyfunctional monolayer-protected gold clusters | |
| Jia et al. | Bioactivity-protected electrochemiluminescence biosensor using gold nanoclusters as the low-potential luminophor and Cu2S snowflake as co-reaction accelerator for procalcitonin analysis | |
| Liu et al. | An interface comprising molecular wires and poly (ethylene glycol) spacer units self-assembled on carbon electrodes for studies of protein electrochemistry | |
| JP3791930B2 (ja) | ルミネセンスアッセイにおける黒鉛ナノチューブ | |
| Rohde et al. | A non-oxidative approach toward chemically and electrochemically functionalizing Si (111) | |
| Templeton et al. | Redox and fluorophore functionalization of water-soluble, tiopronin-protected gold clusters | |
| EP1042508B1 (fr) | Procedes pour dosages a luminescence amelioree utilisant des microparticules | |
| EP2286234B1 (fr) | Nouveau composite coeur-enveloppe au-ag convenant comme biocapteur | |
| Harper et al. | Maleimide-activated aryl diazonium salts for electrode surface functionalization with biological and redox-active molecules | |
| EP1073902A2 (fr) | Particule de la taille du nanometre comportant une monocouche reactive adsorbee, et son procede d'obtention | |
| CN104374764B (zh) | 一种分析探针、其制备方法和用途 | |
| NZ514682A (en) | Monolayer and electrode for detecting a label-bearing target and method of use thereof | |
| Xu et al. | Surface defect-involved and single-color electrochemiluminescence of gold nanoclusters for immunoassay | |
| JP2538083B2 (ja) | 電気化学的ルミネッセンス性レニウムモイエティ及びそれらの使用方法 | |
| Chen et al. | Simple, clickable protocol for atomic force microscopy tip modification and its application for trace ricin detection by recognition imaging | |
| JP2008502715A (ja) | 新規なdna縫い込み型インターカレータ | |
| Taira et al. | Electrode modification by long-chain, dialkyl disulfide reagent having terminal dinitrophenyl group and its application to impedimetric immunosensors | |
| Mazur et al. | Probing intermolecular communication with surface-attached pyrene | |
| EP3969243A1 (fr) | Capteurs et procédés faisant appel à l'électrochimioluminescence de nanoagrégats métalliques | |
| US7321831B2 (en) | Nucleic acid fragment-fixed electrode and its use | |
| JP2004022424A (ja) | ホスト−ゲスト錯体を含有する光電変換素子用材料 | |
| Sun et al. | Chemical Sensors using Single‐Molecule Electrical Measurements | |
| US7005268B2 (en) | Detection of biopolymers utilizing photo-initiated charge separation | |
| Wang et al. | Polyviologen synthesis by self-assembly assisted grafting | |
| US20080166712A1 (en) | Gene detection method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20001120 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Withdrawal date: 20010624 |